BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • BioTech Events
  • BioTech Company Directory
  • Contact Us
Archives
  • October 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2017
  • March 2014
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • BioTech Events
  • BioTech Company Directory
  • Contact Us
Subscribe

Browsing Tag

COVID-19

3 posts

Coronavirus infection (COVID-19) is an illness caused by the SARS-CoV-2 virus. It is an infectious disease.

According to the World Health Organization, the majority of people who become infected with the COVID-19 virus will experience respiratory illness on mild to moderate scales with recovery that does not require special treatment. However, some who contract the virus will become seriously ill and require medical attention.

Older persons and those who have underlying medical issues such as cardiovascular disease, diabetes, chronic respiratory illness, or cancer are more likely to become seriously ill. COVID-19 can affect anybody at any age and cause serious illness or death regardless of age.

The greatest way to prevent and slow the spread of the virus is to be well-informed about it and how it spreads. Wash your hands or use an alcohol-based rub frequently, avoid touching others, and maintain at least 1 meter of distance from others to prevent infection. When it’s your turn, be vaccinated, and follow local recommendations.

The virus is carried in tiny liquid particles when people cough, sneeze, talk, sing, or breathe. The particles in the air vary from those that are big respiratory droplets to smaller aerosols. It’s crucial to follow respiratory etiquette, such as by coughing into a flexed elbow, and staying home and isolating oneself until you feel well again.

Ministry of Food Drug Safety of South Korea Moderna COVID 19 Vaccine

Biotech NewsModerna Announces Ministry of Food and Drug Safety of South Korea (MFDS) COVID-19 Authorization

  • BioTech Health X
  • May 21, 2021
Moderna, Inc., (NASDAQ: MRNA) has recently been authorized by the Ministry of Food and Drug Safety of South…
0 Shares
0
0
0
0
0
0
0
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive - Virology Experts Weigh In

Biotech NewsCOVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive – Virology Experts Weigh In

  • BioTech Health X
  • May 13, 2021
Professional Major League Baseball organization the New York Yankees have been rocked this week with COVID-19 after 8…
0 Shares
0
0
0
0
0
0
0
SyneuRx CEO Interview Dr Emil Tsai BioTech Health X

BioTech CEO InterviewsSyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections

  • BioTech Health X
  • March 29, 2017
Our BioTech Health X CEO Series continues with an exclusive interview with Dr. Emil Tsai of SyneuRx. Today…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • TaiMed Biologics Unveils Promising Results for Innovative Long-Acting HIV Treatment
  • Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results
  • CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
  • Mayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
  • Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
Recent Comments
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 16, 2023
    TaiMed Biologics Unveils Promising Results for Innovative Long-Acting HIV Treatment
    • September 19, 2022
    Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results
    Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results
    • September 10, 2022
    CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
    CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
    • August 31, 2022
    Mayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
    Mayo-Clinic-Gene-Accelerator
    • August 1, 2022
    Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
    Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
Recent Posts
  • ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
    ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
    • July 28, 2022
  • Brickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement
    Brickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement
    • July 20, 2022
  • Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
    Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
    • July 20, 2022
Categories
  • BioTech CEO Interviews (4)
  • Biotech Info (1)
  • Biotech News (46)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • Our Contributors
  • List of Modern Life Science Technologies
  • Contact Us

Subscribe to
Our Updates

Back to top